Sunitinib as second-line treatment in patients with advanced intrahepa
- This topic has 0 replies, 1 voice, and was last updated 9 years, 6 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Sunitinib as second-line treatment in patients with advanced intrahepatic cholangiocarcinoma (SUN-CK phase II trial): Safety, efficacy, and updated translational results.
http://abstracts.asco.org/158/AbstView_158_140087.html
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.